Literature DB >> 22569850

Evaluating the links between schizophrenia and sleep and circadian rhythm disruption.

David Pritchett1, Katharina Wulff, Peter L Oliver, David M Bannerman, Kay E Davies, Paul J Harrison, Stuart N Peirson, Russell G Foster.   

Abstract

Sleep and circadian rhythm disruption (SCRD) and schizophrenia are often co-morbid. Here, we propose that the co-morbidity of these disorders stems from the involvement of common brain mechanisms. We summarise recent clinical evidence that supports this hypothesis, including the observation that the treatment of SCRD leads to improvements in both the sleep quality and psychiatric symptoms of schizophrenia patients. Moreover, many SCRD-associated pathologies, such as impaired cognitive performance, are routinely observed in schizophrenia. We suggest that these associations can be explored at a mechanistic level by using animal models. Specifically, we predict that SCRD should be observed in schizophrenia-relevant mouse models. There is a rapidly accumulating body of evidence which supports this prediction, as summarised in this review. In light of these emerging data, we highlight other models which warrant investigation, and address the potential challenges associated with modelling schizophrenia and SCRD in rodents. Our view is that an understanding of the mechanistic overlap between SCRD and schizophrenia will ultimately lead to novel treatment approaches, which will not only ameliorate SCRD in schizophrenia patients, but also will improve their broader health problems and overall quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 22569850     DOI: 10.1007/s00702-012-0817-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  192 in total

1.  Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain.

Authors:  Magdalena M Brzózka; Konstantin Radyushkin; Sven P Wichert; Hannelore Ehrenreich; Moritz J Rossner
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

2.  Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.

Authors:  Tatiana V Lipina; Min Wang; Fang Liu; John C Roder
Journal:  Neuropharmacology       Date:  2011-03-02       Impact factor: 5.250

Review 3.  Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.

Authors:  Paul J Harrison; Amanda J Law
Journal:  Biol Psychiatry       Date:  2006-01-25       Impact factor: 13.382

4.  Memory impairment in schizophrenia: a meta-analysis.

Authors:  A Aleman; R Hijman; E H de Haan; R S Kahn
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

5.  Sleep and risk-taking behavior in adolescents.

Authors:  Erin M O'Brien; Jodi A Mindell
Journal:  Behav Sleep Med       Date:  2005       Impact factor: 2.964

Review 6.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Authors:  Lin Mei; Wen-Cheng Xiong
Journal:  Nat Rev Neurosci       Date:  2008-05-14       Impact factor: 34.870

7.  Sleep loss and "divergent" thinking ability.

Authors:  J A Horne
Journal:  Sleep       Date:  1988-12       Impact factor: 5.849

8.  Association between CCK-AR gene and schizophrenia with auditory hallucinations.

Authors:  Ivette Toirac; Julio Sanjuán; Eduardo J Aguilar; Jose C González; Francesc Artigas; Olga Rivero; Carmen Nájera; Maria D Moltó; Rosa de Frutos
Journal:  Psychiatr Genet       Date:  2007-04       Impact factor: 2.458

9.  Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia.

Authors:  Vladimir Vacic; Shane McCarthy; Dheeraj Malhotra; Fiona Murray; Hsun-Hua Chou; Aine Peoples; Vladimir Makarov; Seungtai Yoon; Abhishek Bhandari; Roser Corominas; Lilia M Iakoucheva; Olga Krastoshevsky; Verena Krause; Verónica Larach-Walters; David K Welsh; David Craig; John R Kelsoe; Elliot S Gershon; Suzanne M Leal; Marie Dell Aquila; Derek W Morris; Michael Gill; Aiden Corvin; Paul A Insel; Jon McClellan; Mary-Claire King; Maria Karayiorgou; Deborah L Levy; Lynn E DeLisi; Jonathan Sebat
Journal:  Nature       Date:  2011-02-23       Impact factor: 49.962

Review 10.  Sleep, sleepiness, and alcohol use.

Authors:  T Roehrs; T Roth
Journal:  Alcohol Res Health       Date:  2001
View more
  35 in total

1.  Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα.

Authors:  Jennifer Jager; W Timothy O'Brien; Jessica Manlove; Elizabeth N Krizman; Bin Fang; Zachary Gerhart-Hines; Michael B Robinson; Peter S Klein; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2014-02-19

Review 2.  Circadian rhythms have broad implications for understanding brain and behavior.

Authors:  Rae Silver; Lance J Kriegsfeld
Journal:  Eur J Neurosci       Date:  2014-05-05       Impact factor: 3.386

3.  Excessive Daytime Sleepiness in Schizophrenia: A Naturalistic Clinical Study.

Authors:  Payal Sharma; Reetika Dikshit; Nilesh Shah; Sagar Karia; Avinash De Sousa
Journal:  J Clin Diagn Res       Date:  2016-10-01

4.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

5.  The Neural Basis for Sleep Regulation - Data Assimilation from Animal to Model.

Authors:  Fatemeh Bahari; Camila Tulyaganova; Myles Billard; Kevin Alloway; Bruce J Gluckman
Journal:  Conf Rec Asilomar Conf Signals Syst Comput       Date:  2017-03-06

Review 6.  Sleep, circadian rhythms and health.

Authors:  Russell G Foster
Journal:  Interface Focus       Date:  2020-04-17       Impact factor: 3.906

7.  Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease.

Authors:  E Stuebner; E Vichayanrat; D A Low; C J Mathias; S Isenmann; C A Haensch
Journal:  Clin Auton Res       Date:  2015-02-18       Impact factor: 4.435

8.  State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.

Authors:  Robert W Gould; Michael T Nedelcovych; Xuewen Gong; Erica Tsai; Michael Bubser; Thomas M Bridges; Michael R Wood; Mark E Duggan; Nicholas J Brandon; John Dunlop; Michael W Wood; Magnus Ivarsson; Meredith J Noetzel; J Scott Daniels; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones
Journal:  Neuropharmacology       Date:  2015-11-23       Impact factor: 5.250

9.  Model-based analysis and forecast of sleep-wake regulatory dynamics: Tools and applications to data.

Authors:  F Bahari; J Kimbugwe; K D Alloway; B J Gluckman
Journal:  Chaos       Date:  2021-01       Impact factor: 3.642

10.  Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy.

Authors:  Chiara Scotton; Matteo Bovolenta; Elena Schwartz; Maria Sofia Falzarano; Elena Martoni; Chiara Passarelli; Annarita Armaroli; Hana Osman; Carmelo Rodolico; Sonia Messina; Elena Pegoraro; Adele D'Amico; Enrico Bertini; Francesca Gualandi; Marcella Neri; Rita Selvatici; Patrizia Boffi; Maria Antonietta Maioli; Hanns Lochmüller; Volker Straub; Katherine Bushby; Tiziana Castrignanò; Graziano Pesole; Patrizia Sabatelli; Luciano Merlini; Paola Braghetta; Paolo Bonaldo; Paolo Bernardi; Reghan Foley; Sebahattin Cirak; Irina Zaharieva; Francesco Muntoni; Daniele Capitanio; Cecilia Gelfi; Ekaterina Kotelnikova; Anton Yuryev; Michael Lebowitz; Xiping Zhang; Brian A Hodge; Karyn A Esser; Alessandra Ferlini
Journal:  J Cell Sci       Date:  2016-03-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.